Medicine recalls
|
| |
| Canada: Recall: Jamp-Hydralazine tablet: Affected lot may contain Jamp-Hydralazine 10 mg tablets |
| |
Health Canada announces that JAMP Pharma Corporation is recalling one lot of Jamp-Hydralazine 25mg tablet (lot number: H0224009F) from retailers because the affected lot (Jamp-Hydralazine 25 mg) may contain Jamp-Hydralazine 10 mg tablets.
The product is indicated in the treatment of essential hypertension.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/jamp-hydralazine-tablet-affected-lot-may-contain-jamp-hydralazine-10-mg-tablets
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, Jun 11, 2025
Issued at HKT 17:30
|
| |
